E
The startup develops RNA-targeted therapeutics designed to regulate gene expression for cancer treatment. By focusing on RNA biology, the company aims to provide precise interventions that can improve patient outcomes in oncology.
Updated 2 months ago
Funding
$11M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops RNA-targeted therapeutics designed to regulate gene expression for cancer treatment. By focusing on RNA biology, the company aims to provide precise interventions that can improve patient outcomes in oncology.